Table 1 Clinical response rate and pathological response rate to neoadjuvant chemotherapy
pathological response | all breast cancer (n = 239) | TNBC q(n = 83, 34.7%) | non-TNBC (n = 156, 65.3%) |
|---|---|---|---|
pCR: pathological complete response | |||
 CR: complete response | 91 (38.1%) | 40 (48.2%) | 51 (32.7%) |
non-pCR: non-pathological complete response | |||
 PR: partial response | 118 (49.4%) | 34 (41.0%) | 84 (53.8%) |
 SD: stable disease | 25 (10.5%) | 7 (8.4%) | 18 (11.5%) |
 PD: progressive disease | 5 (2.0%) | 2 (2.4%) | 3 (2.0%) |
RR (CR + PR):response rate | 209 (87.5%) | 74 (89.2%) | 135 (86.5%) |